Selbyville, Delaware, Feb. 18, 2021 (GLOBE NEWSWIRE) -- According to industry experts, global immunohematology market reached a valuation of USD 2 billion in 2019 and to reach USD 3.1 billion to register an appreciable CAGR of 5.6% over the forecast period 2020-2027. Increased pervasiveness of HIV and other target diseases is a major growth propeller for the industry. In fact, Joint United Nations Programme on HIV/AIDS (UNAIDS) stated that approximately 1.7 million new cases of HIV were registered in 2019.
Moreover, the research literature provides a detailed picture of industry segments, including product terrain, end-user spectrum, and geographical scope. Moving to the competitive landscape, the reports emphasizes on the strengths & weaknesses of major players, barriers for new entrants, and the top-winning strategies for sustaining profits in the long run. Additionally, it encompasses valuable data on the industry chain with respect to the upstream suppliers, distributors, and downstream buyers.
Further, growing investments by public and private organizations, along with technological innovations in this field will accelerate the overall immunohematology market expansion over the projected timeline.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3207984/
For the uninitiated, immunohematology is a branch of hematology and transfusion medicine that studies the reaction of antigen-antibodies and analogous phenomena as they are correlated to pathogenesis and clinical indicators of blood diseases. Immunohematology assists in diagnosis of white blood cells, blood antigens, plasma components, and Rh factor in the donor blood. It is generally known as blood banking, which involves creation of blood elements for transfusion. It often reduces transfusion-associated fatalities such as thalassemia and HIV.
Emergence of next-gen immunohematology devices helps healthcare professionals to enhance the efficacy of emergency care to patients. Launche of such devices that cater to specific requirements of end users will bode well for global immunohematology industry in the coming years.
Speaking of the restraints, high cost and lack of awareness about immunohematology products will negatively impact the business landscape over the forecast timespan.
Regional outlook overview:
Asia Pacific, Europe, North America, and Latin America are the key contributors to global immunohematology industry remuneration. North America currently accounts for majority of the industry share, largely creditable to high concentration of market vendors and increasing government support for blood transfusion in the region.
Meanwhile, Asia Pacific market is anticipated to showcase a robust growth rate over 2020-2027. Rising burden of target diseases in emerging economies like India and China, coupled with growing cognizance regarding genetic testing for blood disorders are fostering the regional market expansion.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-immunohematology-market-size-research
Global Immunohematology Market Product Terrain (Revenue, USD Billion, 2017-2027)
- Immunohematology Reagent
- Immunohematology Analyzer
Global Immunohematology Market End User Spectrum (Revenue, USD Billion, 2017-2027)
- Blood Banks
- Hospitals
- Diagnostic Laboratories
Global Immunohematology Market Regional Fragmentation (Revenue, USD Billion, 2017-2027)
North America
- United States
- Canada
Europe
- United Kingdom
- France
- Germany
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Mexico
- Brazil
Rest of the World
Global Immunohematology Market Competitive Dashboard (Revenue, USD Billion, 2017-2027)
- Roche Diagnostics Corp.
- Beckman Coulter, Inc.
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers AG
- Hologic, Inc.
- Becton, Dickinson and Company (BD)
- Grifols S.A.
- Immucor, Inc.
- Bio-Rad Laboratories, Inc.
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Immunohematology Market, by Region, 2018-2027 (USD Billion)
1.2.2. Immunohematology Market, by Product, 2018-2027 (USD Billion)
1.2.3. Immunohematology Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunohematology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunohematology Market Dynamics
3.1. Immunohematology Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Immunohematology Market: Industry Analysis
4.1. Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Immunohematology Market, by Product
5.1. Market Snapshot
5.2. Global Immunohematology Market by Product, Performance - Potential Analysis
5.3. Global Immunohematology Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Immunohematology Market, Sub Segment Analysis
5.4.1. Immunohematology analyser
5.4.2. Immunohematology reagent
Chapter 6. Global Immunohematology Market, by End-User
6.1. Market Snapshot
6.2. Global Immunohematology Market by End-User, Performance - Potential Analysis
6.3. Global Immunohematology Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Immunohematology Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Blood Banks
6.4.3. Diagnostic Laboratories
Chapter 7. Global Immunohematology Market, Regional Analysis
Related Report:
North America Immunohematology Market Share, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2026
North America Immunohematology Market Share Estimated To Exceed USD 1,084.5 Mn By 2026. Increasing prevalence of blood disorders coupled with the growing geriatric population will highly impact North America immunohematology market growth in the forthcoming years. The market is expected to gain traction during the forecast period due to the increase in blood disorders such as HIV, anemia and few types of blood cancer. Also, the launch of novel technologically advanced products will also add to the market growth. North America immunohematology market was led by U.S. market and is estimated to show a positive trend throughout the analysis period. Canada immunohematology is forecasted to follow the U.S. immunohematology market progressing at 5.8% CAGR during the study period. This is due to the increased healthcare spending by Canada and the increasing geriatric population. For instance, as of 2017 Canada spent around 11.5% of the total GDP on healthcare sector.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.